Tissue Factor-Targeted “O2-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tissue Factor-Targeted “O2-Evolving” Nanoparticles for Photodynamic Therapy in Malignant Lymphoma

Published:2020-11-10 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Li Ziying,Yin Yanxue,Jin Weiwei,Zhang Bo,Yan Han,Mei Heng,Wang Huafang,Guo Tao,Shi Wei,Hu Yu

Funder

National Natural Science Foundation of China

Major International Joint Research Programme

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference34 articles.

1. Hypoxia in cancer: significance and impact on clinical outcome;Vaupel;Cancer Metastasis Rev,2007

2. Non-Hodgkin’s B-cell lymphoma: advances in molecular strategies targeting drug resistance;Maxwell;Exp Biol Med (Maywood),2013

3. Targeted photodynamic therapy–a promising strategy of tumor treatment;Bugaj;Photochem Photobiol Sci,2011

4. WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice;Neuschmelting;Theranostics,2018

5. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial;Azzouzi;Lancet Oncol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin’s Lymphoma;Mini-Reviews in Medicinal Chemistry;2023-09-15

2. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies;Journal of Hematology & Oncology;2023-06-23

3. An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas;Pharmaceutics;2023-04-24

4. Current Challenges and Opportunities of Photodynamic Therapy against Cancer;Pharmaceutics;2023-01-18

5. Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy;Biomolecules;2022-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3